HONG KONG, Mar 30, 2020 - (ACN Newswire) - - Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics for unmet needs ...
Arcturus Therapeutics ARCT announced this morning that it has initiated dosing of its Covid-19 vaccine candidate—LUNAR COV-19, (ARCT-021)—in a Phase 1/2 study in collaboration with Duke-NUS Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results